BELLICUM PHARMACEUTICALS, INC.
BELLICUM PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 4061592, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 1 September 2017 and lists its registered address as HOUSTON, United States. 5 shareholders are on record for BELLICUM PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 5 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for BELLICUM PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Boxer Capital, LLC, holding 82.7% — a majority holding — followed by Fidelity Extended Market Index Fund at 6.7%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 8 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Boxer Capital, LLC | 82.7% | California Secretary of State — bizfile Online | |
| Fidelity Extended Market Index Fund | 6.7% | California Secretary of State — bizfile Online | |
| Fidelity NASDAQ Composite Index Fund | 4.2% | California Secretary of State — bizfile Online | |
| B. Riley Wealth Advisors, Inc. | 2.1% | California Secretary of State — bizfile Online | |
| Tekla Capital Management LLCC. | 1.1% | California Secretary of State — bizfile Online |
Officers
5
The Chief Executive Officer of BELLICUM PHARMACEUTICALS, INC. currently on record is David M. Maggio; five officers are currently on record for BELLICUM PHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online.
The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at BELLICUM PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
BELLICUM PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans United States, Germany jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
BELLICUM PHARMACEUTICALS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns BELLICUM PHARMACEUTICALS, INC.?
Five shareholders are currently on record for BELLICUM PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Boxer Capital, LLC, holding 82.7% — a majority holding — followed by Fidelity Extended Market Index Fund at 6.7%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is BELLICUM PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for BELLICUM PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does BELLICUM PHARMACEUTICALS, INC. have on record?
5 shareholders are shown on record for BELLICUM PHARMACEUTICALS, INC.. The register reports 8 in total; only the top 5 by holding are shown here.
What is BELLICUM PHARMACEUTICALS, INC.'s company registration number?
BELLICUM PHARMACEUTICALS, INC.'s registration number is 4061592, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is BELLICUM PHARMACEUTICALS, INC. still an active company?
BELLICUM PHARMACEUTICALS, INC.'s status on California Secretary of State — bizfile Online is listed as active.
When was BELLICUM PHARMACEUTICALS, INC. incorporated?
BELLICUM PHARMACEUTICALS, INC. was incorporated on 1 September 2017, according to California Secretary of State — bizfile Online.
What is BELLICUM PHARMACEUTICALS, INC.'s registered address?
The registered address on file for BELLICUM PHARMACEUTICALS, INC. is HOUSTON, United States.
Who are the officers/directors of BELLICUM PHARMACEUTICALS, INC.?
The Chief Executive Officer of BELLICUM PHARMACEUTICALS, INC. currently on record is David M. Maggio; five officers are currently on record for BELLICUM PHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online. Management authority at BELLICUM PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does BELLICUM PHARMACEUTICALS, INC. have a parent company or subsidiaries?
BELLICUM PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Those 1 subsidiary spans United States, Germany jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to BELLICUM PHARMACEUTICALS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to BELLICUM PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access BELLICUM PHARMACEUTICALS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like BELLICUM PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 5 October 2026.